|Year : 2015 | Volume
| Issue : 3 | Page : 145-152
|Grey zone lesions of breast: Potential areas of error in cytology
Suvradeep Mitra1, Pranab Dey2
1 Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, Punjab and Haryana, India
2 Department of Cytopathology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, Punjab and Haryana, India
Click here for correspondence address and email
|Date of Web Publication||9-Nov-2015|
| Abstract|| |
Fine-needle aspiration cytology (FNAC) of the breast is a rapid, cost-effective, and sensitive procedure to diagnose breast lesions, and was widely employed to diagnose breast lesions in the past. However, in recent times, core needle biopsy of the breast is gaining popularity and acceptability, although FNAC still looms large. There are some intrinsic disadvantages to FNAC, of which the most important is probably difficulty in classification of a significant percentage of breast lesions. Such lesions are usually denoted by the rubric "grey zone lesions of the breast." This article attempts to review these grey zone lesions and highlight the difficulties in diagnosing them.
Keywords: Breast; cytology; fine-needle aspiration cytology (FNAC); grey zone
|How to cite this article:|
Mitra S, Dey P. Grey zone lesions of breast: Potential areas of error in cytology. J Cytol 2015;32:145-52
Since the advent of triple testing for breast malignancies, fine-needle aspiration cytology (FNAC) had become an integral part of the evaluation of breast lesions. Triple testing includes breast self-examination (BSE) or physical examination, mammography and/or ultrasonography, and cytology. ,, FNAC has its own benefits, being a quick and cheap procedure featuring: a short turnover time; high diagnostic accuracy; less patient discomfort; provision of multiple sampling from multiple areas of breast, provision of ancillary tests; and curative relief in some cases, as in case of aspiration of a cyst. ,, However, cytology has the limitation of failure to distinguish between some benign or borderline lesions from the malignant lesions and subtype certain benign breast lesions as well.
To address this problem, guidelines were laid down in 1992 by the National Health Service Breast Screening Programme (NHSBSP), UK and were further modified in 1996 by the National Cancer Institute, Maryland, USA.  These guidelines had proposed five categories to report breast lesions on FNAC, namely, inadequate (C1), benign (C2), atypia probably benign (C3), suspicious of malignancy (C4), and malignant (C5). ,
An "inadequate" report is issued when the material aspirated is scanty or acellular, or there is any technical artefact precluding a proper report. To call a lesion benign, the aspirated sample needs to be adequate with benign cytomorphology. To call a lesion malignant, an adequate sample with malignant cytomorphology is needed. For all practical purposes, reporting of these three categories (C1, C2, and C5) is straightforward with high specificity. The two intermediate categories (C3 and C4), however, evoke considerable debate among pathologists all over the world and form the core area of discussion in this article. ,,
A lesion termed as "atypia probably benign" (C3) means that it has predominantly benign cytomorphology with the presence of some uncommon features. These uncommon features include nuclear pleomorphism and cellular discohesion or therapy-related nucleocytoplasmic changes as an individual change or in combination. In addition, an increase in cellularity can also be associated with any of these features. The lesions termed as "suspicious of malignancy" (C4) include those with some cells showing features of malignancy, in a material that is not diagnostic due to its scantiness, poor preservation, or poor preparation. The lesions with a higher degree of malignant features than C3 are also included in this group even though frankly malignant cells are not present. Moreover, a lesion with overall benign features but with scattered, distinctively malignant cells is also included in this category. In common parlance, a C3 lesion is a benign one with some atypical features, whereas a C4 lesion is probably a malignant one with insufficient material to be diagnosed as a frank malignancy or a lesion with a greater degree of atypia than that of a C3 lesion. ,,
The importance of these two categories (C3 and C4) lies in the buffering they provide to both cytopathologists and the clinicians. It denotes the limitation and diagnostic difficulty on the part of cytopathologists in accurately classifying some of the breast lesions despite adequate sampling at times, whereas it guides a clinician to follow up such lesions with a repeat FNAC or core needle biopsy after a reasonable interval. However, the diagnosis in these categories should not exceed 20% of the lesions and it is preferred if the percentage remains below 15%, as per the NHSBSP guidelines,  to prevent overuse and abuse of such equivocal categories. Different studies have shown the percentage of "true grey zone lesions" (lesions which pose diagnostic difficulty due to the presence of atypical/ suspicious cells and not because of technical limitation) to be close to 2% of all the breast fine-needle aspiration (FNA) cases examined. ,
The "true grey zone lesions" comprise both benign and malignant lesions [Table 1], including fibroadenoma, fibrocystic disease of the breast, papilloma and other papillary lesions of the breast, proliferative breast disease with or without atypia including radial scar and sclerosing adenosis, fat necrosis, phyllodes tumor, lactating breast, lobular carcinoma, tubular carcinoma, mucinous carcinoma, low-grade in situ carcinoma, or ductal carcinoma. ,,,,,,,, Gynecomastia in male breast is also a lesion that causes a dilemma in some cases.
| Biphasic Lesions of the Breast|| |
Fibroadenoma is probably the commonest breast lesion for which FNAC is performed.  Different studies auditing C3 and C4 cases have documented fibroadenoma as being one of the most commonly misdiagnosed lesions that appear as the grey zone lesions. ,,,,,, In cytopathology, the smears are hypercellular with a relatively monomorphic population of ductal cells, some forming monolayered sheets and some forming angulated clusters along with numerous bipolar cells (myoepithelial cells) in the background.
Some degree of atypia, nuclear enlargement, and cellular discohesion is often associated with the aspirates of fibroadenoma, raising the suspicion of a low-grade adenocarcinoma [Figure 1], often compounded by the hypercellularity of the lesions. However, the maintenance of the polarity, the relative blandness of the nuclear chromatin, and the presence of bipolar cells in the background often help in making the correct diagnosis. Fibroadenomas do not show sudden change in tubular diameter or pointed tips, unlike tubular carcinomas. Of special concern are the cases termed as "fibroadenoma with atypia," , as they have the potential to be diagnosed as low-grade malignancies. These lesions are mostly conventional fibroadenomas, though some are truly associated with benign proliferative lesions.
|Figure 1: Discrete ductal cells with nuclear pleomorphism in fi broadenoma (H and E, ×440)|
Click here to view
Being the other important type of biphasic tumor, the phyllodes tumor also constitutes an important grey zone lesion. Distinguishing a benign phyllodes tumor from a (cellular) fibroadenoma is often difficult and depends on the clinicopathological correlation. A lesion of more than 4 cm size with abundant and hypercellular fibromyxoid stroma is usually diagnosed as a phyllodes tumor. Moreover, the epithelial component of phyllodes is broad and rounded as compared to the angulated or staghorn clusters of fibroadenoma. Cytology aspirates cannot also properly distinguish between benign, borderline, and malignant phyllodes tumors ,,, [Figure 2]. Nuclear pleomorphism and number of mitosis increase progressively from a borderline to a malignant phyllodes tumor. However, these features are subjective and difficult to assess on cytology smears. Though the presence of significant cellularity and/or the presence of stromal blood vessels is/are individual indicator/s of a diagnosis of phyllodes tumor, these features lack universality. For example, a sampling error can be the reason for less cellularity, and many fibroadenomas can also be associated with stromal blood vessels.
|Figure 2: Round to spindle cells with marked nuclear pleomorphism in malignant phyllodes tumor of breast. (MGG, ×440)|
Click here to view
An adenomyoepithelioma is a rare cellular biphasic tumor and is difficult to diagnose without the help of ancillary techniques, as the myoepithelial cells can adopt a different morphology, namely, spindle cell, plasmacytoid, epithelioid, clear cell, or even oncocytic. A cellular smear with both epithelial and myoepithelial cells should raise a suspicion of this lesion. In a few cases, intranuclear inclusions are also noted. The atypia associated with some of these lesions often poses problems and portends a false positive diagnosis. ,,,
Fat necrosis usually presents as a breast lump or a radiological density in the breast. The history of trauma is not always obtained. FNA smears show a dirty necrotic background, foamy histiocytes, and numerous other inflammatory cells. These inflammatory cells include neutrophils, lymphocytes, and plasma cells. The preponderance of the cell type depends on the timing of FNA. A neutrophilic infiltrate being predominant in an acute stage, whereas lymphoplasmacytic infiltrate steals the show at a later phase. In addition, epithelioid histiocytes, occasional ill-formed granuloma, and multinucleate giant cells can also be seen. Sometimes there can be capillary proliferation when the lesion reaches an organizing phase.
The major difficulties in this lesion can be because of a clinicoradiological suspicion of a mass, lack of a history of trauma in some cases, reactive atypia in the ductal cells [Figure 3] that may look malignant, and a necrotic background.  However, the preponderance of inflammatory cells and foamy histiocytes as compared to the ductal cells, often scanty in a typical dirty necrotic background, alert an experienced cytopathologist toward the right diagnosis.
Breast FNA from a pregnant or lactating woman often poses a diagnostic challenge. In cytology, a cellular smear with a dispersed/discohesive population of cells with round nuclei, coarse chromatin or hyperchromatic chromatin, and prominent nucleoli raises a suspicion of malignancy. However, numerous naked nuclei, cells containing multivacuolated cytoplasm, scattered inflammatory cells and foamy macrophages, and a bubbly proteinaceous background often help in navigating the cytopathologists toward the right diagnosis. However, it should be kept in mind that sometimes malignancy can be associated with lactation, and lactation in such a situation masks the evidence of malignancy. ,,
Cytology smears in granulomatous inflammation show multiple epithelioid cell granulomas, multinucleate giant cells, inflammatory cells comprising of lymphocytes and plasma cells, and often a necrotic background. Granulomatous inflammation of the breast can be caused by infectious diseases such as tuberculosis or fungus; or it can have noninfectious causes such as sarcoidosis or idiopathic granulomatous mastitis; or sometimes as a part of foreign-body reaction against silicone implant. ,,,,,, Idiopathic granulomatous mastitis is difficult to diagnose in cytology smears as it is a lobulocentric lesion, which is a difficult feature to appreciate in cytology smears. Only the possibility can be suggested, based on history and cytomorphology.  The reactive atypia of the ductal epithelium associated with granulomatous inflammation can sometimes cause a problem in categorization of the lesion.
Radiation induced changes occur in the breast as a result of receiving radiotherapy for breast malignancy itself or some other malignancies such as Hodgkin's lymphoma. The major differentials considered are a recurrence of the breast cancer or a radiation induced atypia or a radiation induced sarcoma in rare cases.  The first two differentials are often quite difficult to distinguish and require significant expertise. The major problem is faced because of radiation-induced atypia, which can be significant. The atypia is seen in the ductal epithelial cells showing loose clusters in a paucicellular FNA smear. A dirty necrotic background can also be seen to add to the problem. Usually the nucleocytoplasmic ratio in these cells is maintained due to an enlargement in both the nucleus and the cytoplasm. The degree of atypia, nuclear membrane irregularity, and nucleolar prominence are often less than what is expected in a case of frank carcinoma, although a cytopathologist is often forced to exercise a sufficient degree of caution to issue a straightforward report in such cases. The cellular cohesion is usually more than that of a case of carcinoma, and the smear has less cellularity. ,
Papillary lesions of breast
The diagnostic challenge with papillary lesions of the breast is twofold: The distinction of the papillary lesions from the other nonpapillary lesions, namely, fibroadenoma, and the distinction of a benign from a malignant papillary lesion. The challenge is compounded by the fact that some of the papillary lesions are impossible to distinguish by cytology, such as intracystic or solid variants of papillary carcinoma.
Cytology smears of papillary lesions are highly cellular, with epithelial cell clusters, singly scattered epithelial cells, and papillary fronds, some of which are "true" in the sense that they contain central fibrovascular cores. Some complex and branching papillae are also noted [Figure 4]a and b. The singly scattered cells have a columnar look or sometimes they look plasmacytoid with eccentric nuclei and moderate to abundant amount of cytoplasm. The background of such lesions is equally important and is characterized by foamy macrophages, apocrine cells, and bipolar cells in a fluid backdrop. The presence of macrophages, apocrine cells, and bipolar cells is associated with a benign papillary lesion rather than a malignant one. In addition, a malignant papillary lesion is more often associated with a higher degree of cellularity, a greater number of singly scattered cells, and more complex papillae with fibrovascular cores. Atypia can be seen in both benign and malignant papillary lesions and is not a discriminating feature. ,,,,,, It is worth mentioning here that a proper classification of a papillary lesion is not always possible even by core needle biopsy and subsequent histopathology. ,
|Figure 4: (a) Papillary clusters of cells in a papillary neoplasm of breast (MGG, ×220); (b) Discrete columnar cells and foamy macrophages in a papillary neoplasm of breast (MGG, ×220)|
Click here to view
Fibroadenomas and fibrocystic change lack in "true" papillae containing fibrovascular cores, and in addition fibroadenomas contain stromal fragments distinguishing them from papillary lesions. 
Proliferative breast diseases
After fibroadenoma, this is probably the second most common group of grey zone lesions. , Benign proliferative breast diseases, rhetorically called the nightmare of breast pathologists, are radial scar and complex sclerosing lesions that show adenosis and stromal fibrosis, often misunderstood as malignant glands causing infiltration and eliciting desmoplasia around them in histopathology. It should be remembered that despite best efforts, the accurate diagnosis of these two lesions is nearly impossible using cytology smears.
FNA smears are variably cellular with epithelial cells in clusters or as a dispersed population in the background of bipolar (myoepithelial) cells as well as hyalinized stromal fragments. The cytological picture is complicated by hypercellularity, discohesive cell population, nuclear atypia, tubular structures, paucity of myoepithelial cells in some lesions, and a dirty background. ,,
Usual ductal hyperplasia (UDH), atypical ductal hyperplasia (ADH), and low-grade ductal carcinoma are extremely difficult to distinguish from each other on cytology smears. While the first two are essentially proliferative breast disease with or without atypia and are preneoplastic conditions, the last one is a low-grade malignancy. UDH without atypia shows epithelial cell clusters with bland chromatin of the epithelial cells. Cellular monomorphism is not a feature of UDH. Myoepithelial cells are seen admixed with the epithelial cell clusters, and cellular streaming can also be noted. The epithelial cell clusters can also adopt complex structures. In contrast, low-grade ductal adenocarcinoma shows cellular monomorphism, absence of myoepithelial cells, nuclear atypia, conspicuous nucleoli, and some features of invasion, which will be discussed later. ADH has features intermediate to UDH and low-grade ductal adenocarcinoma [Figure 5]a and b. The presence of the myoepithelial cells is an important point of discrimination from ductal carcinoma in situ (DCIS). ,,,
|Figure 5: (a) Tight cohesive cluster of cells with nuclear pleomorphism in a proliferating breast disease with atypia (MGG, ×440); (b) Enlarged and hyperchromatic nuclei in a proliferating breast disease with atypia (H and E, ×440)|
Click here to view
| Ductal Carcinoma in Situ (DCIS) and other Invasive Carcinomas of Breast|| |
DCIS and ductal adenocarcinoma
DCIS can be low-grade or high-grade. Low-grade DCIS is non-comedo DCIS (solid sheet, cribriform; cells around a central space and papillary type). Low-grade DCIS shows epithelial cell clusters, sometimes with papillary or cribriform pattern. They show a relatively monomorphic population of cells having round nuclei and small nucleoli. Myoepithelial cells are absent. Macrophages and calcification are seen and necrosis can also be noted. Although necrosis is almost invariably seen in comedo DCIS, the presence of necrosis is not pathognomonic of a high-grade DCIS. In contrast to low-grade DCIS, high-grade DCIS shows cohesive clusters as well as a dispersed population of tumor cells. These tumor cells show a greater degree of nuclear pleomorphism, coarse chromatin, prominent nucleoli, mitotic activity, calcification, and necrotic background. Myoepithelial cells are absent. Low-grade DCIS and ADH are difficult, if not impossible, to distinguish as the distinction is based on quantitative criteria in histopathology and is not just qualitative. In contrast, high-grade DCIS is difficult to differentiate from an invasive ductal carcinoma. ,, The cytological features of invasion are 1) fat infiltration, 2) fibroblast proliferation, 3) elastoid stromal fragments, 4) stromal infiltration, 5) tubule formation by the tumor cells, 6) intracytoplasmic lumina formation, and 7) the presence of lymphocytes around the tumor cells. In addition, 1) macrophages, 2) myoepithelial cells in the epithelial cell clusters, and 3) calcification are more commonly associated with an in situ lesion than invasion. ,,,,,,
FNA smears of tubular carcinoma are cellular and show monolayered or angulated epithelial cell clusters such as fibroadenomas. However, tubular carcinomas show sudden changes in the diameter of the tubules with pointed tips. The cells arrange perpendicularly to the edge of the clusters. Atypia is minimal. The discohesive population of tumor cells is lower and many myoepithelial cells can be seen. Sometimes nuclear grooves and intracytoplasmic vacuoles can also be noted. A stromal component can be seen in the background, which is usually acellular.
Numerous studies had concluded lobular carcinoma to be the most commonly misdiagnosed (false negative) variety of breast malignancy. ,,,, Cytology smears show variable cellularity ranging from low to high with a dispersed population of relatively monomorphic cells with eccentrically placed nuclei, mild nuclear atypia, deceptively bland chromatin, and moderate amount of cytoplasm [Figure 6]. The presence of intracytoplasmic lumina is often considered a telltale feature, though it is not very specific. It has been documented that the cellularity of an invasive lobular carcinoma in cytology smears correlates with the histopathological architectural pattern rather than with the original histopathological cellularity. , The help of ancillary tests such as immunocytochemistry can be taken in doubtful cases combining a "pancytokeratin" and E-cadherin.
|Figure 6: Mildly pleomorphic round cells having intracyoplasmic lumina in occasional cells in lobular carcinoma (MGG, ×440)|
Click here to view
Mucinous (colloid) carcinoma
Mucinous carcinoma is important to diagnose due to two reasons. First, it should be distinguished from the other benign mucinous lesions of the breast, and second, it has a better prognosis than the other invasive carcinomas of the breast. Cytology smears of mucinous carcinoma show cellular aspirate with the tumor cells in clusters, sheet, or as a discrete population dispersed in an abundant amount of extracellular pool of mucin [Figure 7]. The individual cells are relatively monomorphic with eccentrically placed vesicular nuclei, inconspicuous to small nucleoli, and mucin-containing vacuolated cytoplasm. Capillary fragments are often noted in the pool of mucin.
|Figure 7: Malignant cells floating in pool of mucin in mucinous carcinoma (MGG, ×440)|
Click here to view
The major differentials considered in such a lesion are myxoid fibroadenoma, mucocele-like lesion, and fibrocystic change. Mucocele-like lesions are acellular to paucicellular, and the cellularity is contributed by occasional epithelial or myoepithelial cells with minimal atypia. In contrast, a fibrocystic lesion is variably cellular, containing macrophages and apocrine cells in addition to the epithelial and the myoepithelial cells. A myxoid fibroadenoma contains all the classical cytomorphological features of fibroadenoma, such as staghorn epithelial cell clusters, stromal fragments, and bare nuclei in a myxoid background. ,,,,,
Other rare lesions
Adenoid cystic carcinoma is a sufficiently rare tumor of the breast showing acellular hyaline, metachromatic globules (Giemsa) surrounded by basaloid tumor cells in clusters. The basaloid cells are relatively monomorphic and have a high nucleocytoplasmic ratio with round to oval hyperchromatic nuclei, inconspicuous nucleoli, and scant amount of cytoplasm. These cells are arranged around the globules in clusters, sheet, cribriform pattern, and sometimes as single cells. The major differential is collagenous spherulosis, showing similar kind of globules/spherules though the cells lack in the basaloid appearance and numerous myoepithelial cells are present in the background. Pleomorphic adenoma has a metachromatic, feathery, and fibrillary character to the stroma, distinguishing them from those of adenoid cystic carcinoma. ,,
Cribriform carcinoma shows a low nuclear grade and tumor cells in a sheet with cribriform spaces in between. The major difficulty lies in its deceptively benign cytoarchitectural appearance. Cribriform DCIS naturally appears in the differential. The presence of osteoclast-like giant cells is considered to be a rare and nonspecific feature of invasion. ,,
| Conclusion|| |
The categorization of reporting of breast cytology has provided a buffer for the pathologists while providing necessary information to the clinicians and the patients. Whether the presence of both C3 and C4 is needed is a matter of debate, but the presence of such borderline categories definitely provides scope for the cytopathologists to make mistakes and also speaks volumes of the limitations and difficulties in interpretation of the breast cytology smears. Nevertheless, most of the cytology smears are correctly reported and there are only a few lesions that fall in the true grey zone region, being almost unclassifiable, unidentifiable, or undiagnosable by cytology. In such situations, the use of uncertain categories guides the clinician for further management. We have discussed the major grey zone lesions and the reasons for their difficulty in interpretation. Although not an exhaustive one, this discussion should help cytopathologists make the right call.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ariga R, Bloom K, Reddy VB, Kluskens L, Francescatti D, Dowlat K, et al
. Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation. Am J Surg 2002;184:410-3.
Tabbara SO, Frost AR, Stoler MH, Sneige N, Sidawy MK. Changing trends in breast fine-needle aspiration: Results of the Papanicolaou Society of Cytopathology Survey. Diagn Cytopathol 2000;22:126-30.
Ahmed I, Nazir R, Chaudhary MY, Kundi S. Triple assessment of breast lump. J Coll Physicians Surg Pak 2007;17:535-8.
Rosa M, Mohammadi A, Masood S. The value of fine needle aspiration biopsy in the diagnosis and prognostic assessment of palpable breast lesions. Diagn Cytopathol 2012;40:26-34.
Abdel-Hadi M, Abdel-Hamid GF, Abdel-Razek N, Fawzy RK. Should fine-needle aspiration cytology be the first choice diagnostic modality for assessment of all nonpalpable breast lesions? The experience of a breast cancer screening center in Alexandria, Egypt. Diagn Cytopathol 2010;38:880-9.
The uniform approach to breast fine-needle aspiration biopsy. National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees. Diagn Cytopathol 1997;16:295-311.
Deb RA, Matthews P, Elston CW, Ellis IO, Pinder SE. An audit of "equivocal" (C3) and "suspicious" (C4) categories in fine needle aspiration cytology of the breast. Cytopathology 2001;12:219-26.
Kanhoush R, Jorda M, Gomez-Fernandez C, Wang H, Mirzabeigi M, Ghorab Z, et al
. 'Atypical' and 'suspicious' diagnoses in breast aspiration cytology. Cancer 2004;102:164-7.
Shabb NS, Boulos FI, Abdul-Karim FW. Indeterminate and erroneous fine-needle aspirates of breast with focus on the 'true gray zone': A review. Acta Cytol 2013;57:316-31.
al-Kaisi N. The spectrum of the "gray zone" in breast cytology. A review of 186 cases of atypical and suspicious cytology. Acta Cytol 1994;38:898-908.
Howell LP. Equivocal diagnoses in breast aspiration biopsy cytology: Sources of uncertainty and the role of "atypical/indeterminate" terminology. Diagn Cytopathol 1999;21:217-22.
Simsir A, Cangiarella J. Challenging breast lesions: Pitfalls and limitations of fine-needle aspiration and the role of core biopsy in specific lesions. Diagn Cytopathol 2012;40:262-72.
Choi YD, Choi YH, Lee JH, Nam JH, Juhng SW, Choi C. Analysis of fine needle aspiration cytology of the breast: A review of 1,297 cases and correlation with histologic diagnoses. Acta Cytol 2004;48:801-6.
Jamal AA, Mansoor I. Analysis of false positive and false negative cytological diagnosis of breast lesions. Saudi Med J 2001;22:67-71.
Kline TS. Masquerades of malignancy: A review of 4,241 aspirates from the breast. Acta Cytol 1981;25:263-6.
Chaiwun B, Sukhamwang N, Lekawanvijit S, Sukapan K, Rangdaeng S, Muttarak M, et al
. Atypical and suspicious categories in fine needle aspiration cytology of the breast: Histological and mammographical correlation and clinical significance. Singapore Med J 2005;46:706-9.
Kollur SM, El Hag IA. FNA of breast fibroadenoma: Observer variability and review of cytomorphology with cytohistological correlation. Cytopathology 2006;17:239-44.
Stanley MW, Tani EM, Skoog L. Fine-needle aspiration of fibroadenomas of the breast with atypia: A spectrum including cases that cytologically mimic carcinoma. Diagn Cytopathol 1990;6:375-82.
Simsir A, Waisman J, Cangiarella J. Fibroadenomas with atypia: Causes of under- and overdiagnosis by aspiration biopsy. Diagn Cytopathol 2001;25:278-84.
Shabb NS. Phyllodes tumor. Fine needle aspiration cytology of eight cases. Acta Cytol 1997;41:321-6.
Krishnamurthy S, Ashfaq R, Shin HJ, Sneige N. Distinction of phyllodes tumor from fibroadenoma: A reappraisal of an old problem. Cancer 2000;90:342-9.
Bhattarai S, Kapila K, Verma K. Phyllodes tumor of the breast. A cytohistologic study of 80 cases. Acta Cytol 2000;44:790-6.
Chang A, Bassett L, Bose S. Adenomyoepithelioma of the breast: A cytologic dilemma. Report of a case and review of the literature. Diagn Cytopathol 2002;26:191-6.
Iyengar P, Ali SZ, Brogi E. Fine-needle aspiration cytology of mammary adenomyoepithelioma: A study of 12 patients. Cancer 2006;108:250-6.
Laforga JB, Aranda FI, Sevilla F. Adenomyoepithelioma of the breast: Report of two cases with prominent cystic changes and intranuclear inclusions. Diagn Cytopathol 1998;19:55-8.
Aydin O, Cinel L, Egilmez R, Ocal K, Ozer C. Adenomyoepithelioma of the breast. Diagn Cytopathol 2001;25:194-6.
Gupta RK, McHutchison AG, Dowle CS, Simpson JS. Fine-needle aspiration cytodiagnosis of breast masses in pregnant and lactating women and its impact on management. Diagn Cytopathol 1993;9:156-9.
Mitre BK, Kanbour AI, Mauser N. Fine needle aspiration biopsy of breast carcinoma in pregnancy and lactation. Acta Cytol 1997;41:1121-30.
Novotny DB, Maygarden SJ, Shermer RW, Frable WJ. Fine needle aspiration of benign and malignant breast masses associated with pregnancy. Acta Cytol 1991;35:676-86.
Gupta RK. Fine needle aspiration cytology of granulomatous mastitis: A study of 18 cases. Acta Cytol 2010;54:138-41.
Gupta D, Rajwanshi A, Gupta SK, Nijhawan R, Saran RK, Singh R. Fine needle aspiration cytology in the diagnosis of tuberculous mastitis. Acta Cytol 1999;43:191-4.
Martínez-Parra D, Nevado-Santos M, Meléndez-Guerrero B, García-Solano J, Hierro-Guilmain CC, Pérez-Guillermo M. Utility of fine-needle aspiration in the diagnosis of granulomatous lesions of the breast. Diagn Cytopathol 1997;17:108-14.
Banik S, Bishop PW, Ormerod LP, O'Brien TE. Sarcoidosis of the breast. J Clin Pathol 1986;39:446-8.
Nosanchuk JS. Silicone granuloma in breast. Arch Surg 1968;97:583-5.
Farmer C, Stanley MW, Bardales RH, Korourian S, Shah H, Bradsher R, et al
. Mycoses of the breast: Diagnosis by fine-needle aspiration. Diagn Cytopathol 1995;12:51-5.
Poniecka AW, Krasuski P, Gal E, Lubin J, Howard L, Poppiti RJ. Granulomatous inflammation of the breast in a pregnant woman: Report of a case with fine needle aspiration diagnosis. Acta Cytol 2001;45:797-801.
Fitzgibbons PL. Granulomatous mastitis. N Y State J Med 1990;90:287.
Yahalom J, Petrek JA, Biddinger PW, Kessler S, Dershaw DD, McCormick B, et al
. Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992;10:1674-81.
Filomena CA, Jordan AG, Ehya H. Needle aspiration cytology of the irradiated breast. Diagn Cytopathol 1992;8:327-32.
Schnitt SJ, Connolly JL, Harris JR, Cohen RB. Radiation-induced changes in the breast. Hum Pathol 1984;15:545-50.
Simsir A, Waisman J, Thorner K, Cangiarella J. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up. Cancer 2003;99:156-65.
Gomez-Aracil V, Mayayo E, Azua J, Arraiza A. Papillary neoplasms of the breast: Clues in fine needle aspiration cytology. Cytopathology 2002;13:22-30.
Michael CW, Buschmann B. Can true papillary neoplasms of breast and their mimickers be accurately classified by cytology? Cancer 2002;96:92-100.
Bardales RH, Suhrland MJ, Stanley MW. Papillary neoplasms of the breast: Fine-needle aspiration findings in cystic and solid cases. Diagn Cytopathol 1994;10:336-41.
Dawson AE, Mulford DK. Benign versus malignant papillary neoplasms of the breast. Diagnostic clues in fine needle aspiration cytology. Acta Cytol 1994;38:23-8.
Jayaram G, Elsayed EM, Yaccob RB. Papillary breast lesions diagnosed on cytology. Profile of 65 cases. Acta Cytol 2007;51:3-8.
Masood S, Loya A, Khalbuss W. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions? Diagn Cytopathol 2003;28:329-34.
Sydnor MK, Wilson JD, Hijaz TA, Massey HD, Shaw de Paredes ES. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology 2007;242:58-62.
Greenberg ML, Camaris C, Psarianos T, Ung OA, Lee WB. Is there a role for fine-needle aspiration in radial scar/complex sclerosing lesions of the breast? Diagn Cytopathol 1997;16:537-42.
Field A, Mak A. The fine needle aspiration biopsy diagnostic criteria of proliferative breast lesions: A retrospective statistical analysis of criteria for papillomas and radial scar lesions. Diagn Cytopathol 2007;35:386-97.
Lamb J, McGoogan E. Fine needle aspiration cytology of breast in invasive carcinoma of tubular type and in radial scar/complex sclerosing lesions. Cytopathology 1994;5:17-26.
Abendroth CS, Wang HH, Ducatman BS. Comparative features of carcinoma in situ
and atypical ductal hyperplasia of the breast on fine-needle aspiration biopsy specimens. Am J Clin Pathol 1991;96:654-9.
Sidawy MK, Stoler MH, Frable WJ, Frost AR, Masood S, Miller TR, et al
. Interobserver variability in the classification of proliferative breast lesions by fine-needle aspiration: Results of the Papanicolaou Society of Cytopathology Study. Diagn Cytopathol 1998;18:150-65.
Sneige N, Staerkel GA. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ
. Hum Pathol 1994;25:485-92.
McKee GT, Tildsley G, Hammond S. Cytologic diagnosis and grading of ductal carcinoma in situ
. Cancer 1999;87:203-9.
Cangiarella J, Waisman J, Simsir A. Cytologic findings with histologic correlation in 43 cases of mammary intraductal adenocarcinoma diagnosed by aspiration biopsy. Acta Cytol 2003;47:965-72.
Dillon MF, McDermott EW, Quinn CM, O'Doherty A, O'Higgins N, Hill AD. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. J Surg Oncol 2006;93:559-63.
Maygarden SJ, Brock MS, Novotny DB. Are epithelial cells in fat or connective tissue a reliable indicator of tumor invasion in fine-needle aspiration of the breast? Diagn Cytopathol 1997;16:137-42.
Bondeson L, Lindholm K. Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases. Diagn Cytopathol 1997;17:315-20.
Shin HJ, Sneige N. Is a diagnosis of infiltrating versus in situ
ductal carcinoma of the breast possible in fine-needle aspiration specimens? Cancer 1998;84:186-91.
McKee GT, Tambouret RH, Finkelstein D. Fine-needle aspiration cytology of the breast: Invasive vs. in situ
carcinoma. Diagn Cytopathol 2001;25:73-7.
Rajesh L, Dey P, Joshi K. Fine needle aspiration cytology of lobular breast carcinoma. Comparison with other breast lesions. Acta Cytol 2003;47:177-82.
Joshi A, Kumar N, Verma K. Diagnostic challenge of lobular carcinoma on aspiration cytology. Diagn Cytopathol 1998;18:179-83.
Leach C, Howell LP. Cytodiagnosis of classic lobular carcinoma and its variants. Acta Cytol 1992;36:199-202.
Hwang S, Ioffe O, Lee I, Waisman J, Cangiarella J, Simsir A. Cytologic diagnosis of invasive lobular carcinoma: Factors associated with negative and equivocal diagnoses. Diagn Cytopathol 2004;31:87-93.
Lerma E, Fumanal V, Carreras A, Esteva E, Prat J. Undetected invasive lobular carcinoma of the breast: Review of false-negative smears. Diagn Cytopathol 2000;23:303-7.
Abdulla M, Hombal S, al-Juwaiser A, Stankovich D, Ahmed M, Ajrawi T. Cellularity of lobular carcinoma and its relationship to false negative fine needle aspiration results. Acta Cytol 2000;44:625-32.
Ventura K, Cangiarella J, Lee I, Moreira A, Waisman J, Simsir A. Aspiration biopsy of mammary lesions with abundant extracellular mucinous material. Review of 43 cases with surgical follow-up. Am J Clin Pathol 2003;120:194-202.
Hamele-Bena D, Cranor ML, Rosen PP. Mammary mucocele-like lesions. Benign and malignant. Am J Surg Pathol 1996;20:1081-5.
Dawson AE, Mulford DK. Fine needle aspiration of mucinous (colloid) breast carcinoma. Nuclear grading and mammographic and cytologic findings. Acta Cytol 1998;42:668-72.
Duane GB, Kanter MH, Branigan T, Chang C. A morphologic and morphometric study of cells from colloid carcinoma of the breast obtained by fine needle aspiration. Distinction from other breast lesions. Acta Cytol 1987;31:742-50.
Stanley MW, Tani EM, Rutquist LE, Skoog L. Adenoid cystic carcinoma of the breast: Diagnosis by fine-needle aspiration. Diagn Cytopathol 1993;9:184-7.
Saqi A, Mercado CL, Hamele-Bena D. Adenoid cystic carcinoma of the breast diagnosed by fine-needle aspiration. Diagn Cytopathol 2004;30:271-4.
Kasagawa T, Suzuki M, Doki T, Fujimori T, Itami M, Takenouchi T, et al
. Two cases of adenoid cystic carcinoma: Preoperative cytological findings were useful in determining treatment strategy. Breast Cancer 2006;13:112-6.
Cai G, Simsir A, Cangiarella J. Invasive mammary carcinoma with osteoclast-like giant cells diagnosed by fine-needle aspiration biopsy: Review of the cytologic literature and distinction from other mammary lesions containing giant cells. Diagn Cytopathol 2004;30:396-400.
Phillipson J, Ostrzega N. Fine needle aspiration of invasive cribriform carcinoma with benign osteoclast-like giant cells of histiocytic origin. A case report. Acta Cytol 1994;38:479-82.
Ng WK. Fine needle aspiration cytology of invasive cribriform carcinoma of the breast with osteoclastlike giant cells: A case report. Acta Cytol 2001;45:593-8.
Department of Cytopathology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012, Punjab and Haryana
Source of Support: None, Conflict of Interest: None
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7]
|This article has been cited by|
||Accuracy of the International Academy of Cytology Yokohama system of breast cytology reporting for fine needle aspiration biopsy of the breast in a dedicated breast care setting
| ||Akansha Agarwal, Divya Singh, Anoushika Mehan, Pranoy Paul, Neeti Puri, Priyanka Gupta, Anjum Syed, Shalinee Rao, Nilotpal Chowdhury, Bina Ravi |
| ||Diagnostic Cytopathology. 2021; 49(2): 195 |
|[Pubmed] | [DOI]|
||Implementation of the International Academy of Cytology Yokohama standardized reporting for breast cytopathology: An 8-year retrospective study
| ||Yin Ping Wong, Evelyna Prisha Vincent James, Mohammad Affieq Aiman Mohammad Azhar, Yogeswaran Krishnamoorthy, Nur Aqilah Zainudin, Farhah Zamara, Geok Chin Tan, Shamsul Azhar Shah, Nurismah Md Isa, Asmazila Baharoom |
| ||Diagnostic Cytopathology. 2021; 49(6): 718 |
|[Pubmed] | [DOI]|
A retrospective analysis of 512 cases of breast fine needle aspiration cytology utilizing the recently proposed
Yokohama system for reporting breast cytopathology
| ||Nutan Dixit, Shalini Trivedi, Vikas Kumar Bansal |
| ||Diagnostic Cytopathology. 2021; 49(9): 1022 |
|[Pubmed] | [DOI]|
||Primary Small Cell Malignancies of the Breast: Are They Rare Malignancies?
| ||Kemal Behzatoglu, Fernando Schmitt |
| ||Acta Cytologica. 2021; : 1 |
|[Pubmed] | [DOI]|
||UTILITY OF FNAC AS A FIRST LINE INVESTIGATION IN THE EVALUATION OF PALPABLE BREAST LUMPS WITH HISTOPATHOLOGICAL CORRELATION: A FIVE YEAR STUDY.
| ||Manisha Khare, Saraswathi J, Yogita Sable, Yasmeen Khatib, Prajakta Gupte |
| ||GLOBAL JOURNAL FOR RESEARCH ANALYSIS. 2021; : 253 |
|[Pubmed] | [DOI]|
||Fine-Needle Aspiration Cytology (FNAC) is a reliable diagnostic tool for small breast lesions (= 1.0?cm): a 20-year retrospective study
| ||Jessica Aline Tomelin de Cursi, Mari‚ngela Esther Alencar Marques, Cristina Andrea Campos de Assis Cunha Castro, Fernando Carlos Schmitt, Cleverson Teixeira Soares |
| ||Surgical and Experimental Pathology. 2020; 3(1) |
|[Pubmed] | [DOI]|
||Cytological Findings in Benign Phyllodes Tumors
| ||Perikala†Vijayananda Kumar, Maral Mokhtari |
| ||Acta Cytologica. 2019; 63(1): 23 |
|[Pubmed] | [DOI]|
| Article Access Statistics|
| Viewed||12267 |
| Printed||147 |
| Emailed||0 |
| PDF Downloaded||885 |
| Comments ||[Add] |
| Cited by others ||7 |